IBD in Clinical Practice: Long-Term Disease Management and Surgery - 2019

Inflammatory Bowel Diseases in Clinical Practice: An Interactive Tutorial for Patient Management 2017
0.75 AMA PRA Category 1 Credit(s)
Launch Date:
May 02, 2019
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Physicians and gastroenterologists, nurse practitioners, and physician assistants

Relevant Terms:

Inflammatory bowel diseases; Crohn's disease; Ulcerative colitis

Miguel Regueiro, MD

Miguel Regueiro, MD
Chair, Department of Gastroenterology and Hepatology
Professor, Lerner College of Medicine
Cleveland Clinic
Cleveland, OH

Miguel Regueiro, MD, is the chair of the Department of Gastroenterology, Hepatology, and Nutrition, and vice chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as medical co-chair of Digestive Disease and Surgical Institute Research Governance committee and is a professor of medicine at the Lerner College of Medicine, Cleveland Clinic. He also holds the Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology, Digestive Disease and Surgery Institute.

Dr Regueiro’s main clinical and research interest is inflammatory bowel disease (IBD) with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease.  Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty, medical home and neighborhood for IBD. Dr Regueiro is investigating alternative models of care in population-based health that integrates patients, payors, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs

Hans Herfarth, MD, PhD

Hans Herfarth, MD, PhD
Professor of Medicine
University of North Carolina
Chapel Hill, NC

Hans Herfarth, MD, PhD, is a professor of medicine at the University of North Carolina (UNC), where he is currently the co-director of the IBD Multidisciplinary Center. Dr Herfarth’s main research interests comprise the investigation of novel diagnostic and therapeutic approaches in patients with inflammatory bowel diseases (IBD). His focus is the conceptualization and execution of investigator initiated clinical studies in IBD, which are funded by the NIH, the Crohn's & Colitis Foundation, and private as well as industry associated foundations. Dr Herfarth is the author of more than 220 journal articles, book chapters, and reviews related to IBD.
1. Decide which medical treatment to use in acute IBD flares and for long-term disease management
2. Identify IBD characteristics for which surgery is indicated

Join leading IBD experts in this interactive activity where you will have the opportunity to follow a patient to learn about the long-term management and surgery indications of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Hans Herfarth, MD, PhD, has affiliations with Alivio, Allergan, AMAG, Boehringer-Ingelheim, Celtrion, Finch, Lycera, Merck, Pfizer, PureTech, Seres (Consultant); Artizan, Pfizer (Research).  

Miguel Reguerio, MD, has affiliations with AbbVie, Allergan, Amgen, Celgene, Genentech, Gilead, Janssen, Miraca Labs, Pfizer, Salix, Seres, Takeda, UCB (Advisory Board, Consultant); AbbVie, Janssen, Takeda (Research); AbbVie, Janssen, Pfizer, Salix, Shire, Takeda, UCB (Unrestricted Educational Grants).

Planners and Managers 
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose. The Crohn’s & Colitis Foundation planners and managers have nothing to disclose.


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Estimated time to complete: 45 minutes
Medium: Internet

There is no fee for this educational activity.

Supported by independent educational grants from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc.


There are no fees for participating and receiving CME/CE credit for this activity. During the period May 2, 2019 through May 1, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.   

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately. If you would like to contact Postgraduate Institute for Medicine, please email information@pimed.com.  


Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003,
Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.
  Supported Phones & Tablets:
  Android 4.0.3 and above
  iPhone/iPad with iOS 6.1 or above